2021 annual financial data
INmune Bio Inc. 2021 Net margin
INmune Bio Inc. 2021 net margin with verified reported values.
Direct answer
Net margin was -16,762.43%.
Operating income was -29,153,000 USD and net income was -30,340,000 USD.
Operating cash flow was -28,504,000 USD.
Get free INmune Bio Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 181,000 USD
- Operating income
- -29,153,000 USD
- Net income
- -30,340,000 USD
- Operating cash flow
- -28,504,000 USD